Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias
Clinical trial NCT04754399 · COMPLETED
Trial details
- NCT number
- NCT04754399
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-16
- Primary completion
- 2023-10-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.